BDSX
Biodesix Inc.
$7.15
+$0.02(+0.28%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$52.27M
Volume
58.66K
52W Range
$0.17 - $35.80
Target Price
$36.00
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $45.6M | $54.5M | $38.2M | $49.1M | $71.3M | ||
| Total Revenue | $45.6M | $54.5M | $38.2M | $49.1M | $71.3M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $22.0M | $30.5M | $14.2M | $166.0K | $15.6M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $23.6M | $24.0M | $24.1M | $49.1M | $71.3M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $68.5M | $95.4M | $74.6M | $90.4M | $105.8M | ||
| Research & Development | $10.8M | $12.8M | $13.1M | $10.0M | $9.6M | ||
| Research Expense | $10.8M | $12.8M | $13.1M | $10.0M | $9.6M | ||
| Selling, General & Administrative | $34.9M | $50.5M | $61.5M | $67.4M | $80.5M | ||
| Selling & Marketing Expenses | -- | $50.5M | -- | $7.2M | $7.6M | ||
| General & Administrative Expenses | $34.9M | $50.5M | $61.5M | $67.4M | $80.5M | ||
| Salaries & Wages | -- | $-4.9M | -- | $5.4M | $6.6M | ||
| Depreciation & Amortization | -- | -- | -- | $3.3M | $5.8M | ||
| Depreciation & Amortization | -- | -- | -- | $3.3M | $5.8M | ||
| Amortization | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | ||
| Other Operating Expenses | $-22.8M | $-32.1M | $-14.2M | $-57.0K | $-48.0K | ||
| OPERATING INCOME | |||||||
| Operating income | $-22.9M | $-40.9M | $-50.6M | $-41.3M | $-34.5M | ||
| EBITDA | $-20.8M | $-35.5M | $-51.5M | $-37.1M | $-26.4M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $7.6M | $4.5M | $8.1M | $9.5M | $8.3M | ||
| Intinc | $18.0K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-7.6M | $-4.5M | $-8.1M | $-9.5M | $-8.3M | ||
| Other Income/Expense | $860.0K | $-2.3M | $-6.9M | $1.3M | $175.0K | ||
| Other Special Charges | $-860.0K | $2.3M | $-6.8M | $-1.3M | $-175.0K | ||
| SPECIAL ITEMS | |||||||
| Special Income Charges | -- | -- | $-81.0K | $-44.0K | $-238.0K | ||
| Impairment of Capital Assets | -- | -- | $81.0K | $44.0K | $238.0K | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-23.7M | $-38.7M | $-57.4M | $-42.6M | $-34.7M | ||
| Pre-Tax Income | $14.2M | $21.1M | $-65.4M | $-29.6M | $-42.9M | ||
| NET INCOME | |||||||
| Net Income | $-31.4M | $-43.2M | $-65.4M | $-52.1M | $-42.9M | ||
| Net Income (Continuing Operations) | $-31.4M | $-43.2M | $-65.4M | $-52.1M | $-42.9M | ||
| Net Income (Discontinued Operations) | $-31.4M | $-43.2M | $-65.4M | $-52.1M | $-42.9M | ||
| Net Income (Common Stockholders) | $-31.4M | $-43.2M | $-65.4M | $-29.6M | $-42.9M | ||
| Normalized Income | -- | -- | -- | -- | $-18.7M | ||
| TOTALS | |||||||
| Total Expenses | $68.5M | $95.4M | $88.7M | $90.6M | $105.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $4.8M | $27.4M | $42.1M | $82.1M | $129.7M | ||
| Average Shares Outstanding (Diluted) | $4.8M | $27.3M | $42.1M | $82.1M | $129.7M | ||
| Shares Outstanding | $26.6M | $31.3M | $78.0M | $96.9M | $146.0M | ||
| Basic EPS | $-6.48 | -- | $-1.55 | $-0.64 | $-0.33 | ||
| Basic EPS (Continuing Operations) | $-6.48 | -- | $-1.55 | $-0.64 | $-0.33 | ||
| Diluted EPS | $-6.48 | $-1.58 | $-1.55 | $-0.64 | $-0.33 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.58 | $-1.55 | $-0.64 | $-0.33 | ||
| OTHER METRICS | |||||||
| Interest Expense Operating | $-1.8M | $-1.7M | -- | -- | -- | ||
| Other Gand A | $34.9M | $50.5M | $61.5M | $67.4M | $80.5M | ||
| Rent And Landing Fees | $1.7M | $-1.2M | -- | -- | -- | ||
| Selling Expense | -- | $50.5M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDSX | $7.15 | +0.3% | 58.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |